14th Aug 2008 16:32
Protherics PLC
Notification of Major Interest in Shares
London, UK; Brentwood, TN, US; 14 August 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces that, on 12 August 2008, the following notification of interest in the ordinary share capital of the Company was received today from Aviva plc.
1. Reason for the notification (please tick the appropriate box or boxes) |
||
An acquisition voting rights |
x |
|
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||
An event changing the breakdown of voting rights |
||
Other (please specify): CHANGE TO THE TOTAL NUMBER OF VOTING RIGHTS IN ISSUE |
||
2. Full name of person(s) subject to the notification obligation: |
Aviva plc & its subsidiaries |
|
3. Full name of shareholder(s) (if different from 2.): |
Registered Holder: BNY Norwich Union Nominees Limited 6,741,190* Chase GA Group Nominees Limited 18,382,959* Chase Nominees Limited979,009* CUIM Nominee Limited4,812,551* Vidacos Nominees Limited70,303* BNP Paribas - London636,429 Chase Nominees Limited 3,518,325 State Street Nominees Limited 9,577,375 Vidacos Nominees Limited 2,003,920 *denotes direct interest |
|
4. Date of the transaction (and date on which the threshold is crossed or reached if different): |
11 August 2008 |
|
5. Date on which issuer notified: |
12 August 2008 |
|
6. Threshold(s) that is/are crossed or reached: |
8% to 9% Change at Direct Interest level |
|
7. Notified details: |
A: Voting rights attached to shares |
|||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the Triggering transaction |
Resulting situation after the triggering transaction |
|||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights |
|||
Direct |
Direct |
Indirect |
Direct |
Indirect |
|||
Ordinary Shares GB0007029209 |
46,151,488 |
46,151,488 |
30,986,012 |
30,986,012 |
15,736,049 |
9.06% |
4.60% |
B: Financial Instruments |
||||
Resulting situation after the triggering transaction |
||||
Type of financial instrument |
Expiration date |
Exercise/ Conversion Period/ Date |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
N/A |
||||
Total (A+B) |
|
Number of voting rights |
% of voting rights |
46,722,061 |
13.66% |
8. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable : |
See Section 3 |
Proxy Voting: |
|
9. Name of the proxy holder: |
See Section 3 |
10. Number of voting rights proxy holder will cease to hold: |
|
11. Date on which proxy holder will cease to hold voting rights: |
|
12. Additional information: |
Figures are based on a total number of voting rights of 342,159,034 |
| Ends |
For further information please contact:
Protherics |
|
Nick Staples, Director of Corporate Affairs |
+44 (0) 7919 480510 |
Julie Vickers, Company Secretary |
+44 (0)1928 518010 |
Financial Dynamics - press enquiries |
|
London: Ben Atwell, Lara Mott |
+44 (0) 20 7831 3113 |
New York: John Capodanno |
+1 212 850 5600 |
Or visit www.protherics.com
Related Shares:
Aviva